NCT00634192 - Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

August 31, 2009

Conditions

Pseudomonas Infections

Interventions

DRUG

tobramycin

1x300mg/d inhaled

DRUG

tobramycin

2x300mg/d inhaled

Trial Locations (8)

Novartis Investigator Site, Berlin

Novartis Investigator Site, Cologne

Novartis Investigator Site, Frankfurt

Novartis Investigator site, Halle

Novartis Investigator Site, Hamburg

Novartis Investigator Site, Hanover

Novartis Investigator Site, Heidelberg

Novartis Investigator Site, Munich